Home › Researcher directory › Quentin Philippot
Quentin Philippot
Affiliation : Hôpital Necker-Enfants Malades · Inserm · Université Paris Cité · Human Genetic of Infectious Diseases · Institut des Maladies Génétiques Imagine
- 11Publications (affiliation in France)
- 123Total publications
- 12104Citations
- 36h-index
Research profile
Quentin Philippot has 11 indexed publications (2021–2026). Their work appears mainly in “The Journal of Experimental Medicine”, “Proceedings of the National Academy of Sciences” and “medRxiv”. Their most cited article, “Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deat” (2021), has been cited 611 times. 3 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in United States, Spain, Singapore, Germany.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Immunodeficiency and Autoimmune Disorders
- interferon and immune responses
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Publications (11)
- Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis
- High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
- High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
- Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
- Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
- Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
- Impaired IL-23–dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency
- Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
- The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Publication venues
- The Journal of Experimental Medicine × 4
- Proceedings of the National Academy of Sciences × 2
- medRxiv × 1
- Nature × 1
- Journal of Clinical Immunology × 1
- Research Square × 1
Publications per year
- 20263
- 20233
- 20224
- 20211
Collaborations
Partner institutions : Assistance Publique – Hôpitaux de Paris · Rockefeller University · Sorbonne Université · Centre National de la Recherche Scientifique · Hospices Civils de Lyon
Co-authors’ countries : United States · Spain · Singapore · Germany
Co-authors
- Jérémie Rosain
- Tom Le Voyer
- Mélanie Migaud
- Lucy Bizien
- Adrian Gervais
- Paul Bastard
- Emmanuelle Jouanguy
- Anne Puel
- Laurent Abel
- Kahina Saker
- Jean‐Laurent Casanova
- Aurélie Cobat
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.